Atlas Trials

Allogeneic SCT of CordIn™, in Patients With Hemoglobinopathies

Clinical trial NCT02504619 · TERMINATED

Trial details

NCT number
NCT02504619
Sponsor
Gamida Cell ltd
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Sickle Cell DiseaseThalassemia
Start date
2016-04-04
Primary completion
2016-08-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.